BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6418815)

  • 1. Revertants from the HLA class II regulatory mutant 6.1.6: implications for the regulation of Ia gene expression.
    Levine F; Pious D
    J Immunol; 1984 Feb; 132(2):959-62. PubMed ID: 6418815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation of expression of histocompatibility antigens on the cell surface; molecular genetic basis.
    Petrányi GG
    Folia Biol (Praha); 1995; 41(3-4):163-77. PubMed ID: 7589712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
    Wilson KM; Labeta MO; Pawelec G; Fernandez N
    Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of HLA class II and invariant chain genes.
    Levine F; Erlich HA; Mach B; Pious D
    J Immunol; 1985 Jan; 134(1):637-40. PubMed ID: 3964823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of class II gene expression in a murine pre-B cell line.
    Polla BS; Poljak A; Geier S; Nathenson SG; Ohara J; Paul WE; Glimcher LH
    Fed Proc; 1986 Dec; 45(13):2995-9. PubMed ID: 3536599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for two trans-acting genes regulating HLA class II antigen expression.
    Salter RD; Alexander J; Levine F; Pious D; Cresswell P
    J Immunol; 1985 Dec; 135(6):4235-8. PubMed ID: 3934280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
    Monji T; McCormack AL; Yates JR; Pious D
    J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
    Szöllósi J; Horejsí V; Bene L; Angelisová P; Damjanovich S
    J Immunol; 1996 Oct; 157(7):2939-46. PubMed ID: 8816400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II MHC transcriptional mutants are defective in higher order complex formation.
    Riley JL; Boss JM
    J Immunol; 1993 Dec; 151(12):6942-53. PubMed ID: 8258702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells.
    Dellabona P; Latron F; Maffei A; Scarpellino L; Accolla RS
    J Immunol; 1989 Apr; 142(8):2902-10. PubMed ID: 2495328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique DR-related B cell differentiation antigen.
    Shipp MA; Schwartz BD; Kannapell CC; Griffith RC; Scott MG; Ahmed P; Davie JM; Nahm MH
    J Immunol; 1983 Nov; 131(5):2458-67. PubMed ID: 6415171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC.
    Malnati MS; Ceman S; Weston M; DeMars R; Long EO
    J Immunol; 1993 Dec; 151(12):6751-6. PubMed ID: 8258689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
    Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS
    J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells.
    Fling SP; Arp B; Pious D
    Nature; 1994 Apr; 368(6471):554-8. PubMed ID: 8139690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Demonstration of transcriptional regulation of protein kinase C by class II anti-HLA antibodies in human CA cells of the lymphoblastoid line].
    Brick-Ghannam C; Charron D
    Bull Cancer; 1993 Sep; 80(9):780-5. PubMed ID: 8204957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.